Related Experiment Video
Updated: May 22, 2026

Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
Published on: August 14, 2019
Experimental and theoretical advances in functional understanding of flavonoids as anti-tumor agents
Bandarugattu V Babu1, Naveen K Konduru, Waro Nakanishi
1Department of Chemistry, Indian Institute of Technology Roorkee, Roorkee 247667, India.
Abstract:
The potential of flavonoids to act as anti-tumor agents has been recognized but not fully understood because flavonoids are acting at several stages in cancer progression with distinct structure-function relationships. A whole family of structurally different flavonoids is herein described by reviewing some critical aspects of their pro-oxidant behavior in vitro/vivo and in cell systems by which they may work as antioxidants. Different classes of flavonoids (chalcones, flavones, isoflavones, flavanols, flavanones and anthocyanins) are synthetically mimicked using natural product structure-antioxidant activity relationships that are relevant for their enhanced function against cancer as well as severe inflammation conditions under which an increased oxidative stress is often implicated. In the context of the common mechanisms of flavonoid action, clinical data on benefits of flavonoids in fighting against cancer are discussed. A structural basis needed to improve antioxidant activity of these agents is elaborated in more detail.
Insights
Flavonoids show anti-tumor potential by acting as antioxidants at various cancer stages. Understanding their structure-activity relationships can enhance their effectiveness against cancer and inflammation.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Flavonoids are recognized for anti-tumor potential, but their mechanisms and structure-function relationships are not fully understood.
- Flavonoids exert effects at multiple stages of cancer progression.
- Their antioxidant and pro-oxidant behaviors are critical to their biological activity.
Purpose of the Study:
- To review the pro-oxidant and antioxidant behavior of diverse flavonoid classes.
- To explore structure-activity relationships for enhanced anti-cancer and anti-inflammatory functions.
- To discuss clinical data and structural basis for improving flavonoid efficacy.
Main Methods:
- Review of literature on flavonoid structure, antioxidant activity, and cancer mechanisms.
- Analysis of structure-function relationships across different flavonoid subclasses (chalcones, flavones, isoflavones, flavanols, flavanones, anthocyanins).
- Examination of in vitro, in vivo, and cell system data.
Main Results:
- Flavonoids exhibit distinct structure-function relationships influencing their anti-cancer effects.
- Their pro-oxidant and antioxidant activities are context-dependent and crucial for therapeutic action.
- Specific structural features can be optimized to enhance antioxidant capacity.
Conclusions:
- Flavonoids possess significant potential as anti-tumor and anti-inflammatory agents.
- Optimizing flavonoid structures based on antioxidant activity is key to improving their clinical benefits.
- Further research into structure-activity relationships will advance their application in cancer therapy.
More Related Videos
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers
Published on: September 26, 2019
Related Concept Videos
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...